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ABSTRACT Simulation studies have been performed to evaluate the utility of site-directed spin labeling for determining the
structures of protein-ligand complexes, given a known protein structure. Two protein-ligand complexes were used as model
systems for these studies: a 1.9-Å-resolution x-ray structure of a dihydrofolate reductase mutant complexed with metho-
trexate, and a 1.5-Å-resolution x-ray structure of the V-Src tyrosine kinase SH2 domain complexed with a five-residue
phosphopeptide. Nitroxide spin labels were modeled at five dihydrofolate reductase residue positions and at four SH2 domain
residue positions. For both systems, after energy minimization, conformational ensembles of the spin-labeled residues were
generated by simulated annealing while holding the remainder of the protein-ligand complex fixed. Effective distances,
simulating those that could be obtained from 1H-NMR relaxation measurements, were calculated between ligand protons and
the spin labels. These were converted to restraints with several different levels of precision. Restrained simulated annealing
calculations were then performed with the aim of reproducing target ligand-binding modes. The effects of incorporating a few
supplementary short-range (5.0 Å) distance restraints were also examined. For the dihydrofolate reductase-methotrexate
complex, the ligand-binding mode was reproduced reasonably well using relatively tight spin-label restraints, but metho-
trexate was poorly localized using loose spin-label restraints. Short-range and spin-label restraints proved to be comple-
mentary. For the SH2 domain-phosphopeptide complex without the short-range restraints, the peptide did not localize to the
correct depth in the binding groove; nevertheless, the orientation and internal conformation of the peptide was reproduced
moderately well. Use of the spin-label restraints in conjunction with the short-range restraints resulted in relatively well defined
structural ensembles. These results indicate that restraints derived from site-directed spin labeling can contribute significantly
to defining the orientations and conformations of bound ligands. Accurate ligand localization appears to require either a few
supplementary short-range distance restraints, or relatively tight spin-label restraints, with at least one spin label positioned
so that some of the restraints draw the ligand into the binding pocket in the latter case.
INTRODUCTION
In recent years, methodological advances have significantly
increased the upper size limit of proteins for which detailed
structural information can be obtained using NMR spectros-
copy (Arrowsmith and Wu, 1998; Farmer and Venters,
1998; Gardner and Kay, 1998; Wider and Wu¨thrich, 1999).
Global folds for monomeric proteins as large as 42 kDa
have been determined (Mueller et al., 2000). In general, for
proteins larger than 30 kDa, NMR assignments are ob-
tainable only for a subset of the proton resonances, i.e., the
backbone amide protons and the protons of specifically
labeled residues (Metzler et al., 1996; Goto et al., 1999).
This limits the number of nuclear Overhauser effect (NOE)
restraints available for structure determination. To obtain
accurately converged structures of larger proteins, it may
often be necessary to include additional information, such as
dipolar coupling restraints (Mueller et al., 2000) or re-
straints derived from paramagnetic relaxation rate enhance-
ments (Battiste and Wagner, 2000; Gaponenko et al., 2000).
Data on the locations, orientations, and conformations of
bound ligands also become more difficult to obtain with
increasing protein size. Isotope filtering and editing meth-
ods (Fesik, 1988, 1991; Otting and Wu¨thrich, 1990; Breeze,
2000) can be applied to acquire intra-ligand and protein-
ligand NOE restraints. Due to limited assignments for the
1H resonances of the protein, the number of protein-ligand
NOE restraints that can be obtained will generally be quite
low for large proteins. Transferred NOE experiments (Clore
and Gronenborn, 1982, 1983; Campbell and Sykes, 1993;
Ni and Scheraga, 1994) can be applied to determine the
internal conformations of bound ligands in large systems,
but these experiments are applicable only to ligands of
relatively low affinity, and they do not provide any infor-
mation on the location and orientation of the bound ligand.
Thus, there is a clear need for NMR approaches aimed at
determining ligand-binding modes for large proteins.
An approach that has been used for many years in bio-
molecular NMR to obtain structural information is the mea-
surement of nuclear relaxation rate enhancements caused by
proximity to a paramagnetic center (McConnell, 1967;
Swift, 1974; Berliner, 1976; Berliner, 1979; Holtzman,
1984). The measured rate enhancements afford estimates of
proton-electron distances. A number of studies have ex-
ploited naturally occurring paramagnetic metal ion binding
sites within proteins (Lee and Sykes, 1980; Frederick et al.,
1988; Ray and Rao, 1988), whereas others have utilized
paramagnetic ligands (Anglister et al., 1984; de Jong et al.,
1989; Johnson et al., 1999; Mahoney et al., 2000).
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A general method for incorporating paramagnetic centers
into proteins is site-directed spin labeling (SDSL) (Hubbell
and Altenbach, 1994; Hubbell et al., 1998). In this approach,
a nitroxide-containing compound, such as a methanethio-
sulfonate spin label (Fig. 1), is covalently attached to a
cysteine residue in a protein containing only one such
residue. Site-directed mutagenesis is used to introduce a
single cysteine residue at a suitable surface location and, if
necessary, to remove native cysteines. Dipolar interactions
with the unpaired electron of the spin label will enhance the
relaxation rates of protons within a range of 25–30 Å,
allowing distance restraints to be obtained. SDSL has re-
cently been applied to characterize the denatured states of
staphylococcal nuclease (Gillespie and Shortle, 1997a,b)
and protein L (Yi et al., 2000) and for determining the
global folds of proteins in their native state (Battiste and
Wagner, 2000; Gaponenko et al., 2000).
In addition to the applications mentioned above, SDSL
may also provide structural information for bound ligands,
given a known protein structure. This method should be
applicable in cases where intermolecular NOE-based meth-
ods encounter difficulties, such as with weakly binding
ligands, or with large proteins that are unassigned or only
partially assigned. Several protein mutants, each with a spin
label attached at a different strategic location near the li-
gand-binding site, could provide detailed structural data.
In this article, the potential utility of SDSL for charac-
terizing protein-ligand complexes is addressed by simula-
tions, using a 1.9-Å-resolution x-ray structure of a mutant
dihydrofolate reductase complexed with methotrexate
(Brown et al., 1993) (Protein Data Bank (PDB) entry 1DHI)
and a 1.5-Å-resolution x-ray structure of the V-Src tyrosine
kinase SH2 domain complexed with a five-residue phos-
phopeptide (Waksman et al., 1992) (PDB entry 1SHA) as
model systems. Given the potential flexibility of the spin-
labeled side chain (Mchaourab et al., 1996, 1999) and the
long-range nature of the electron-proton distance restraints,
it is important to investigate the utility of such restraints for
defining ligand-binding modes by simulation studies before
undertaking experimental work. Herein, the ability of SDSL
restraints to reproduce two known protein-ligand complexes
is evaluated. Approximate distance restraints have been
derived from ensembles that widely sample the conforma-
tional space accessible to the spin-labeled side chains. These
restraints are used in simulated annealing calculations, and
their ability to reproduce the overall target ligand-binding
modes and internal conformations is assessed. The effects of
incorporating a minimal number of short-range (NOE-type)
distance restraints on the accuracy of the computed binding
modes are also evaluated. The results indicate that SDSL
restraints can contribute significantly to defining the orien-
tations and conformations of bound ligands. Accurate li-
gand localization is more difficult to achieve using only
SDSL restraints. Potential applications and improvements
to the methodology are discussed.
Background
To obtain SDSL distance restraints to a bound ligand, the
contributions to the bound-state proton longitudinal and/or
transverse relaxation rates due to the paramagnetic center
must be determined. For small peptides and drug-like or-
ganic compounds, the ligand’s proton spectrum will gener-
ally be well resolved, allowing the use of one-dimensional
(1D) pulse sequences for measurement of the longitudinal
(R1) and transverse (R2) relaxation rates. For more complex
ligands, two-dimensional (2D) homonuclear methods for
measuring proton relaxation rates have been developed (Ar-
seniev et al., 1986; Kay and Prestegard, 1988). Measure-
ments should be feasible for both the slow and fast ligand
exchange regimes. For the latter, relaxation rates could be
determined for the averaged (free and bound) ligand reso-
nance positions. In the case of slow exchange, protein 13C,
15N, and 2H labeling combined with isotopic filtering meth-
ods (Fesik, 1988, 1991; Otting and Wu¨thrich, 1990; Breeze,
2000) should allow ligand proton relaxation rates to be
measured. In the fast exchange case, the fraction of ligand
bound to the protein (fb) must be known.
For estimating absolute electron-proton distances, the
correlation time c for each electron-proton dipolar interac-
tion must be determined or approximated. For individual
electron-proton dipolar interactions, c can be determined
from the ratio of the bound-state paramagnetic contributions
to R1 (R1,para) measured at two different field strengths,
from the ratio of the bound-state paramagnetic contributions
to R2 (R2,para) measured at two different field strengths, or
from the ratio R1,para/R2,para at one field strength. Alterna-
tively, all of the c values can be approximated by r, the
overall rotational correlation time for the protein-ligand
complex. This latter approach is feasible when r is short
relative to both the electronic relaxation time and the bound-
state lifetime. However, this approach will introduce some
FIGURE 1 A commonly used cysteine-specific spin label ((1-oxy-
2,2,5,5-tetramethyl-3-pyrroline-3-methyl)methanethiosulfonate). The
simulations reported in this article are based on using this compound to
produce spin-labeled proteins.
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systematic errors into the derived distances depending on
how much r differs from the true individual c values, e.g.,
due to internal dynamics or rotational anisotropy. R1,para and
R2,para are functions of c and the electron-proton distance r
(Kosen, 1989).
METHODS
Derivation of simulated distance restraints
All calculations were performed with the X-PLOR program (Bru¨nger,
1992), unless noted otherwise. The coordinates of the mutant dihydrofolate
reductase-methotrexate complex were obtained from the PDB (entry
1DHI), as were the coordinates of the V-Src tyrosine kinase SH2 domain
complexed with a five-residue phosphopeptide (pY-V-P-M-L; entry
1SHA). All of the hydrogen atoms were built on to the proteins and ligands
using the HBUILD routine of X-PLOR. Parameters for methotrexate were
generated using QUANTA (MSI, Burlington, MA). Bond lengths and
angles for the phosphate group of the phosphopeptide were derived directly
from the 1SHA coordinates. Side chains corresponding to those obtained
by reacting the methanethiosulfonate spin label shown in Fig. 1 with a
cysteine residue were built on to positions 18, 33, 71, 109, and 146 of
dihydrofolate reductase and on to 11, 52, 65, and 74 of the SH2 domain,
using the BUILD routines of X-PLOR. These positions were chosen by
visual inspection. Parameters defining the bond lengths and bond angles for
this residue type were derived by calculations on the nitroxide radical
performed with the SAM1 (Dewar et al., 1993) semi-empirical SCF-MO
methodology. The restricted open shell Hartree-Fock approach was used to
treat the radical’s doublet electronic state, and the molecular geometry was
fully optimized.
After building on the hydrogens, the dihydrofolate reductase-methotrex-
ate complex was subjected to unrestrained energy minimization using the
Powell method. The resulting conformation of the complex has an overall
protein backbone atom root mean square difference (RMSD) to the original
x-ray structure of 0.65 Å. Likewise, the SH2 domain-phosphopeptide
complex was energy minimized, and the resulting conformation of the
complex has an overall backbone atom RMSD (protein and phosphopep-
tide) to the original x-ray structure of 0.78 Å. These energy-minimized
structures served as the target binding modes for all subsequent calcula-
tions.
Fifty conformations of each side chain were generated by unrestrained
simulated annealing (Nilges et al., 1988) by varying the initial velocity
random number seed. All atoms of the spin-labeled residues were allowed
to move during these calculations. For both systems, the ligand and the
remainder of the protein were held fixed throughout. The spin label
positions are well separated in both complexes, allowing all spin-labeled
side chains to be present simultaneously during the calculations. The
high-temperature phase of annealing protocol consisted of 10 ps at 1000 K.
The form of the restraint potential and repulsive non-bonded interactions
were adjusted to their final settings, and the temperature was gradually
lowered to 100 K, followed by a final 2000 steps of unrestrained Powell
minimization. Electrostatic, attractive van der Waals, and empirical dihe-
dral terms were excluded from the potential function.
In the case of the dihydrofolate reductase-methotrexate complex, 2 of
the 50 structures with varied spin-labeled side-chain conformations were
deleted from the ensemble due to unrealistic, high-energy burial of a
spin-labeled side chain. All 50 structures were retained in the case of the
SH2 domain-phosphopeptide complex. Using the ensembles of structures
with varied spin-labeled side-chain conformations, effective distances were
computed from the nitrogens of the spin-labeled side chains to ligand
protons. Effective distances were computed as r31/3 averaged over all
structures. This assumes that any internal motions that modulate r (e.g.,
motions of the spin-labeled side chain) are fast relative to r. Averaging
was also performed over all methylene pairs, methyl protons, and equiv-
alent aromatic protons. Prochiral protons and prochiral methyl groups were
assumed not to be stereospecifically assigned. For both the dihydrofolate
reductase-methotrexate and the SH2 domain-phosphopeptide complexes,
three sets of SDSL restraints were derived by adding (for upper bounds)
and subtracting (for lower bounds) 5%, 10% or 20% of the calculated
effective distance from each restraint. These bounds were selected to span
the likely error range of experimental restraints. In practice, distance errors
can be obtained from errors of the relaxation rates and standard error
propagation methods (e.g., Jacob et al., 1999; Johnson et al., 1999). For
effective distances 25 Å, lower bounds only of 20 Å were used. The use
of lower bound restraints assumes that protons more than 25 Å from the
spin label would experience a negligible relaxation enhancement. For both
complexes, there were no effective distances 8 Å. The effects of elimi-
nating a significant fraction of the restraints were examined in the case of
the SH2 domain-phosphopeptide complex.
For the SH2 domain-phosphopeptide complex, nine short-range (5.0
Å) distance restraints were derived. These include one restraint to enforce
a salt bridge between the phosphate of the peptide and the Arg 32 side
chain, which is a conserved interaction in all known SH2 domain-phos-
phopeptide structures. The remaining eight short-range restraints simulate
NOEs that could be derived from an isoleucine-leucine-valine-labeled
sample (Metzler et al., 1996), assuming a 5.0-Å cutoff for observing an
intermolecular NOE. For the dihydrofolate reductase-methotrexate com-
plex, eight short-range restraints were derived between ligand protons and
backbone amide protons of the protein, again assuming a 5.0-Å cutoff.
These simulate NOEs that could be obtained for a 2H/13C/15N-labeled
protein for which only backbone atom assignments are available, and for
which only NOEs to exchangeable protons of the protein are observable.
The short-range restraints were classified into bins corresponding to strong,
medium, and weak NOEs on the basis of the distance observed in the target
complex. The strong, medium, and weak NOE bins correspond to upper
bounds of 2.5 Å, 3.5 Å (SH2 domain-phosphopeptide) or 4.0 Å (dihydro-
folate reductase-methotrexate), and 5.0 Å, respectively, with additions for
equivalent and prochiral protons. Lower bounds for the short-range re-
straints were set uniformly to 1.8 Å.
Modeling based on simulated distance restraints
The following protocol was used for both systems utilizing the simulated
distance restraints. Structures were calculated by restrained simulated
annealing (Nilges et al., 1988), using the ensembles with varied spin-
labeled side-chain conformations described above for the starting coordi-
nates. The ligands were subjected to random translations (within 	20 Å
along x, y, and z) and random rotations (0–360° around the x, y, and z axes)
to randomize the starting locations and orientations. The ligands and all
atoms of the spin-labeled residues were allowed to move during the
simulated annealing calculations; all other protein atoms were held fixed.
Distance restraints involving methylene, methyl, and equivalent aromatic
protons were treated using the “R-3” averaging option in X-PLOR
(Bru¨nger, 1992). A force constant of 50 kcal/mol Å2 was used for all
distance restraints. Electrostatic, attractive van der Waals, and empirical
dihedral terms were excluded from the potential function.
The simulated annealing protocol (Nilges et al., 1988) consisted of 15
ps at 1000 K, followed by restraint potential and non-bonded interaction
adjustment, temperature lowering to 100 K, and a final 2000 steps of
restrained Powell minimization. Structures were selected for the final
ensembles on the basis of their total restraint energies. RMSD values for
the ligands were calculated in the reference frame of the protein and after
superposition of the calculated ligand conformations on to the target ligand
conformations. The former reflects differences in location, orientation, and
conformation, whereas the latter is determined by internal conformational
differences only. Structures were visualized using InsightII, version 98.0
(MSI); this program was used to produce Figs. 2–7.
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RESULTS
Dihydrofolate reductase-methotrexate complex
Spin-labeled side chains corresponding to the product of
reacting (1-oxy-2,2,5,5-tetramethyl-3-pyrroline-3-methyl)-
methanethiosulfonate (Fig. 1) with a cysteine residue were
built on to five selected positions of dihydrofolate reduc-
tase. These side chains simulate those that would be ob-
tained for the following spin-labeled single-site mutants:
N18C, R33C, R71C, K109C, and Q146C. The residues
chosen for introducing the spin label were selected based on
solvent exposure, proximity to the binding pocket, lack of
direct interactions with the ligand, and good separation
between the locations of attachment. The K109C mutant
(Fig. 2) is particularly noteworthy, because this spin label is
in a position that can be characterized as behind or beneath
the ligand-binding pocket.
Fig. 2 shows an ensemble of 48 structures in which the
conformations of the five spin-labeled residues were ran-
domized by unrestrained simulated annealing. Fig. 2 also
shows the target binding mode of methotrexate. Effective
distances (see Methods) were calculated from the side-chain
nitrogen atom of each spin label to protons of methotrexate.
After averaging over the methyl, methylene, and NH2 group
protons, this procedure yielded 50 effective distances. Of
these, only one was greater than 25 Å; this restraint was
incorporated with only a lower bound (20 Å). The remain-
ing 49 restraints ranged between 13 and 25 Å and were
treated with varying levels of precision, as described below.
For all of the resulting structural ensembles discussed be-
low, there are no SDSL restraint violations 0.1 Å.
In the following, structural ensembles are characterized
by three different RMSD values, referred to as RMSD1,
RMSD2, and RMSD3, as described and summarized in
Table 1. RMSD1 reflects the similarity of the internal con-
formations of the computed methotrexate structures to the
internal conformation of the target, RMSD2 measures the
precision with which the methotrexate binding mode is
determined without reference to the target structure, and
RMSD3 gauges how well the target binding mode (location,
orientation, and internal conformation) is reproduced.
Fig. 3 shows an ensemble of 48 converged structures
(ENS1) obtained with SDSL restraints. The 49 SDSL re-
straints ranging between 13 and 25 Å were incorporated
using error bounds of 	10% of the effective distances. In
Fig. 3, the superposition in the reference frame of the
protein is shown. The overall binding mode, as reflected by
RMSD3 (2.81 Å; Table 1), is reproduced with modest
precision. Methotrexate tends to localize slightly above the
target location. With reference to the average structure
rather than the target binding mode, the localization is better
defined (RMSD2 
 1.50 Å; Table 1). The internal confor-
mation with respect to the target is reproduced moderately
well (RMSD1 
 1.17 Å; Table 1).
The results described above indicate that SDSL restraints
with 	10% error bounds do not precisely define the bound
location of methotrexate. To ascertain the effects of increas-
ing or decreasing the error bounds on the SDSL restraints,
two additional ensembles were calculated. An ensemble of
48 converged structures (ENS2) was obtained with error
bounds of	20% on the SDSL restraints. The RMSD values
for ENS2 (Table 1) demonstrate a decrease in precision
FIGURE 2 Ensemble of 48 structures of dihydrofolate reductase com-
plexed with methotrexate, with randomized spin-labeled residue confor-
mations. The protein backbone conformation is depicted by the medium
gray ribbon, and all heavy atoms of the methotrexate (target binding mode)
are shown in black. The spin-labeled side chains (with residue numbers)
are shown in light gray, with the side-chain nitrogen atoms shown in black.
Effective electron-proton distance restraints were derived from this ensem-
ble.
TABLE 1 Methotrexate RMSD values (Å) for the five
computed structural ensembles of the dihydrofolate
reductase-methotrexate complex
ENS1 ENS2 ENS3 ENS4 ENS5
Nstruct* 48 48 46 23 48
RMSD1 1.17 1.65 0.95 1.57 1.13
RMSD2 1.50 2.52 1.06 2.34 1.04
RMSD3 2.81 4.94 1.95 4.11 1.86
ENS1, ensemble obtained with SDSL restraints with 	10% error bounds;
ENS2, ensemble obtained with SDSL restraints with 	20% error bounds;
ENS3, ensemble obtained with SDSL restraints with 	5% error bounds;
ENS4, ensemble obtained with short-range distance restraints only; ENS5,
ensemble obtained with SDSL restraints (	10%) and short-range distance
restraints; RMSD1, average heavy atom RMSD to the target methotrexate
conformation, after superposition on to the target methotrexate conforma-
tion; RMSD2, average heavy atom RMSD to the average methotrexate
structure in the reference frame of the protein; RMSD3, average heavy
atom RMSD to the target methotrexate structure in the reference frame of
the protein.
*Number of converged structures in the ensemble.
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relative to ENS1, both the overall binding mode and internal
conformation. In particular, the RMSD relative to the target
binding mode increases to 4.94 Å. Decreasing the error
bounds on the SDSL restraints to 	5% produced an ensem-
ble of 46 converged structures (ENS3). The RMSD values
for ENS3 (Table 1) demonstrate an increase in precision
relative to ENS1 and ENS2. The RMSD value for overall
binding mode with respect to the target binding mode
(RMSD3) is 1.95 Å, and the RMSD value of the internal
conformation with respect to the target conformation
(RMSD1) is 0.95 Å (Table 1).
To determine the effects of incorporating a few short-
range restraints, two additional ensembles were calculated.
An ensemble (ENS4) was derived using only eight short-
range restraints between ligand protons and backbone amide
protons of dihydrofolate reductase. This ensemble serves as
a necessary benchmark for calculations that combine the
short-range and SDSL restraints. The short-range restraints
alone do not define the binding mode very well (Table 1).
The eight short-range restraints were combined with SDSL
restraints (	10% error bounds) to produce ENS5 (Fig. 4).
This ensemble has considerably lower values for RMSD2
and RMSD3 (Table 1) than the ensemble produced using
just the SDSL restraints with 	10% error bounds (ENS1).
The accuracy of the binding mode displayed by ENS5 is
similar to that obtained using tight (	5% error bounds)
SDSL restraints only (ENS3). These results indicate that
short-range and SDSL restraints can act synergistically to
produce a relatively well-defined binding mode.
V-Src SH2 domain-phosphopeptide complex
Spin-labeled side chains were built on to four selected
positions of the SH2 domain that simulate those that would
be obtained for the following spin-labeled single-site mu-
tants: T11C, K52C, D65C, and R74C. Unlike the dihydro-
folate reductase-methotrexate case, no spin-labeled side
chain can be characterized as behind or beneath the binding
groove.
Fig. 5 shows the target phosphopeptide binding mode and
an ensemble of 50 structures with randomized conforma-
tions of the four spin-labeled residues. Effective distances
were calculated from each spin label to non-exchangeable
protons of the phosphopeptide. After averaging over the
methyl, methylene, and equivalent aromatic protons, this
procedure yielded 76 effective distances. Of these, 14 were
greater than 25 Å; these were treated as restraints with only
lower bounds (20 Å). The remaining 62 restraints ranged
between 8 and 25 Å. For all of the structural ensembles
discussed below, there are no SDSL restraint violations
FIGURE 3 Ensemble of 48 converged structures of dihydrofolate reduc-
tase complexed with methotrexate obtained using SDSL restraints with
	10% error bounds, using no short-range restraints. Structures are shown
in the reference frame of the protein coordinates. The protein backbone
conformation is depicted by the medium gray ribbon, and all heavy atoms
of the methotrexate in its target binding mode are depicted by the thick
black stick diagram. The methotrexate binding modes derived by restrained
simulated annealing are depicted by thin dark gray stick diagrams. The
spin-labeled side chains are shown in light gray, with the side-chain
nitrogen atoms shown in black.
FIGURE 4 Ensemble of 48 converged structures of dihydrofolate reduc-
tase complexed with methotrexate obtained using SDSL restraints with
	10% error bounds, using also eight short-range restraints. Structures are
shown in the reference frame of the protein coordinates. The gray-scale
coding used is the same as that in Fig. 3.
Spin Labeling for Protein-Ligand Complexes 1279
Biophysical Journal 81(3) 1275–1284
0.1 Å. The SH2 domain-phosphopeptide structural en-
sembles are characterized by six different RMSD values
(RMSD1 through RMSD6) for both backbone atoms and all
heavy atoms, as described in Table 2 .
Fig. 6 shows an ensemble of 46 converged structures
(ENS1) obtained with the 14 lower bound SDSL restraints
and with the 62 SDSL restraints ranging between 8 and 25
Å; the latter were incorporated using error bounds of	10%
of the effective distances. In Fig. 6 a, the superposition in
the reference frame of the protein is shown. The overall
binding mode, as reflected by RMSD5 and RMSD6 (Table
2), is not reproduced very well. Both of these values exceed
5.0 Å. The phosphopeptide tends to localize well above the
binding groove, because there are no restraints to direct the
phosphopeptide deep into the binding groove. With refer-
ence to the average structure rather than the target binding
mode, the localization is still not very well defined, with
RMSD3 
 2.95 Å and RMSD4 
 3.39 Å (Table 2). The
internal conformation with respect to the target (Fig. 6 b) is
reproduced moderately well, with RMSD1 
 0.88 Å and
RMSD2 
 1.87 Å (Table 2).
The SDSL restraints alone do not accurately define the
location of the bound phosphopeptide. As in the dihydro-
folate reductase-methotrexate case, the effects of adding
several short-range distance restraints were examined. In
total, nine short-range restraints were incorporated into the
subsequent calculations. One of these enforces a hydrogen
bond between the phosphate group of the phosphopeptide
and the strictly conserved R32 side chain (PDB entry 1SHA
residue numbering). The remaining eight restraints are be-
tween M4 of the phosphopeptide and I71 and L94 of the
protein. These represent NOE restraints that could be de-
rived using an isoleucine-leucine-valine-labeled protein
sample (Metzler et al., 1996).
An ensemble of 50 converged structures (ENS2) was
computed using only the short-range restraints. The short-
range restraints alone result in somewhat better localization
than that obtained using only the SDSL restraints, with both
RMSD5 and RMSD6 less than 3.0 Å (Table 2) in the former
case. However, the internal conformation with respect to the
target is reproduced less well, with RMSD1 
 1.46 Å and
RMSD2 
 2.48 Å for ENS2 (Table 2).
Using the short-range restraints in conjunction with the
SDSL restraints (	10% error bounds), an ensemble of 47
converged structures (ENS3) was obtained (Fig. 7). This set
of structures is well defined, both with respect to overall
binding mode and internal conformation (Table 2). Focus-
ing on RMSD5 (1.35 Å) and RMSD6 (1.63 Å), it is clear
that the overall binding mode (Fig. 7 a) is much better
defined than with SDSL restraints alone (ENS1) or with the
short-range restraints alone (ENS2). The internal conforma-
tion (Fig. 7 b) is also well defined, with an average back-
bone atom RMSD to the target (RMSD1) of 0.55 Å.
Three additional ensembles of the SH2 domain-phos-
phopeptide system were calculated to ascertain the effects
FIGURE 5 Ensemble of 50 structures of the V-Src tyrosine kinase SH2
domain complexed with a five-residue phosphopeptide, with randomized
spin-labeled residue conformations. The protein backbone conformation is
depicted by the medium gray ribbon, and all heavy atoms of the phos-
phopeptide (target binding mode) are shown in black. The spin-labeled side
chains (with residue numbers) are shown in light gray, with the side-chain
nitrogen atoms shown in black. Effective electron-proton distance re-
straints were derived from this ensemble.
TABLE 2 Phosphopeptide RMSD values (Å) for the six
computed structural ensembles of the V-Src tyrosine kinase
SH2 domain/phosphopeptide complex
ENS1 ENS2 ENS3 ENS4 ENS5 ENS6
Nstruct* 46 50 47 48 22 50
RMSD1 0.88 1.46 0.55 0.76 0.35 0.99
RMSD2 1.87 2.48 1.41 1.63 1.20 1.99
RMSD3 2.95 1.46 0.71 0.94 0.46 1.09
RMSD4 3.39 1.80 0.93 1.25 0.70 1.42
RMSD5 5.01 2.50 1.35 1.51 1.09 2.13
RMSD6 5.81 2.99 1.63 1.91 1.41 2.45
ENS1, ensemble obtained with SDSL restraints (	10%), using no short-
range distance restraints; ENS2, ensemble obtained with short-range dis-
tance restraints only; ENS3, ensemble obtained with SDSL restraints
(	10%) and short-range distance restraints; ENS4, ensemble obtained with
SDSL restraints (	20%) and short-range distance restraints; ENS5, en-
semble obtained with SDSL restraints (	5%) and short-range distance
restraints; ENS6, ensemble obtained with the reduced number of SDSL
restraints (	10%) and short range restraints. RMSD1, average backbone
atom (N, C, and C) RMSD to the target phosphopeptide conformation,
after superposition on to the target phosphopeptide backbone atoms;
RMSD2, average all heavy atom RMSD to the target phosphopeptide
conformation, after superposition on to all heavy atoms of the target
phosphopeptide; RMSD3, average backbone atom (N, C, and C) RMSD
to the average phosphopeptide structure in the reference frame of the
protein; RMSD4, average all heavy atom RMSD to the average phos-
phopeptide structure in the reference frame of the protein; RMSD5, aver-
age backbone atom (N, C, and C) RMSD to the target phosphopeptide
structure in the reference frame of the protein; RMSD6, average all heavy
atom RMSD to the target phosphopeptide structure in the reference frame
of the protein.
*Number of converged structures in the ensemble.
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of increasing or decreasing the error bounds on the SDSL
restraints while retaining the short-range restraints, and to
ascertain the effects of eliminating a significant fraction of
the restraints. An ensemble of 48 converged structures
(ENS4) was obtained with error bounds of	20% on the full
set of SDSL restraints. Whereas the RMSD values for ENS4
(Table 2) demonstrate a decrease in precision relative to
ENS3, both the overall binding mode and internal confor-
mation are still better defined than in ENS1 or ENS2.
Decreasing the error bounds on the full set of SDSL re-
straints to 	5% produced an ensemble of 22 converged
structures (ENS5). (Convergence proved to be significantly
more difficult to obtain with the tight error bounds in this
system.) The RMSD values for ENS5 (Table 2) demonstrate
an increase in precision relative to ENS3. The overall bind-
ing mode and internal conformation are well defined in
ENS5. Finally, an ensemble (ENS6) was computed in which
all restraints involving the following ligand 1H resonances
were eliminated: V2  and -methyl; P3  and ; M4  and
L5 ; and  and -methyl. These resonances are most likely
to be involved in overlaps in a 1D 1H-NMR spectrum. For
ENS6, 8 short-range and 44 SDSL restraints (	10% error
bounds) were retained. The RMSD values for ENS6 (Table
2) are between those of ENS2 and ENS3, indicating that a
reduced number of SDSL restraints still produces an im-
provement over the results obtained with short-range re-
straints only (ENS2).
FIGURE 6 Ensemble of 46 converged structures of the V-Src tyrosine
kinase SH2 domain complexed with a five-residue phosphopeptide ob-
tained using SDSL restraints with 	10% error bounds, using no short-
range distance restraints. (a) Structures in the reference frame of the protein
coordinates. The protein backbone conformation is depicted by the medium
gray ribbon, and all heavy atoms of the phosphopeptide in its target binding
mode are depicted by the thick black stick diagram. The phosphopeptide
binding modes derived by restrained simulated annealing are depicted by
thin dark gray stick diagrams. The spin-labeled side chains are shown in
light gray, with the side-chain nitrogen atoms shown in black. (b) Stereo-
view (relaxed eye) of the phosphopeptide backbone N, C, C, and O atoms,
with the conformations derived by restrained simulated annealing (dark
gray) superimposed on to the target peptide backbone conformation
(black).
FIGURE 7 Ensemble of 47 converged structures of the V-Src tyrosine
kinase SH2 domain complexed with a five-residue phosphopeptide ob-
tained using SDSL restraints with 	10% error bounds, using also nine
short-range distance restraints. (a) Structures in the reference frame of the
protein coordinates. The gray-scale coding used is the same as that in Fig.
6 a. (b) Stereoview (relaxed eye) of the phosphopeptide backbone N, C,
C, and O atoms, with the conformations derived by restrained simulated
annealing (dark gray) superimposed on to the target peptide backbone
conformation (black).
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DISCUSSION
The simulations described in this article are based on the
following considerations. 1) It is assumed that a majority of
ligand proton resonances can be assigned and that relaxation
rates can be measured. Stereospecific assignments are not
assumed for prochiral methylene protons or prochiral
methyl groups when deriving restraints. 2) It is assumed that
paramagnetic contributions to the relaxation rates can be
measured for ligand protons with effective distances be-
tween 8 and 25 Å of the nitrogen of the spin-labeled side
chain. This range is consistent with those reported in the
literature (Gillespie and Shortle, 1997b; Dunham et al.,
1998; Jacob et al., 1999; Johnson et al., 1999; Battiste et al.,
2000; Gaponenko et al., 2000). 3) It is assumed that a
suitable structure of the protein in question is available and
that the boundaries of the binding pocket are known rea-
sonably well. 4) It is assumed that the mode of ligand
binding is unperturbed by the spin label. This could be
supported experimentally by measuring the affinity of the
ligand for each spin-labeled protein. For proteins with a
resolved 1H-15N heteronuclear single quantum coherence
(HSQC) spectrum, highly similar protein chemical shift
changes should be induced by ligand binding if the mode is
unperturbed. 5) It is assumed that the spin-labeled side
chains must be treated as flexible. Even if a particular
spin-labeled residue is relatively rigid due to its location
(Mchaourab et al., 1996), it is assumed that its conformation
is unknown. 6) Several short-range distance restraints may
be required for accurate ligand localization. Alternatively,
moderately accurate ligand localization can be achieved
with tight SDSL restraints when at least some of these
restraints direct the ligand into the binding site. However,
high levels of both precision and accuracy on the SDSL
restraints may be difficult to achieve, and a suitable spin
label placement beneath or behind the binding site will not
be feasible in general, especially for larger proteins.
An advantage of the approach is that the number of
restraints obtainable is approximately given by the number
of spin-labeled sites multiplied by the number of resolvable
ligand proton resonances. Protons that are too close or too
far from the paramagnetic center for measurement of the
paramagnetic contributions to their relaxation rates can still
be restrained with upper or lower distance bounds, respec-
tively. This consideration also holds for protein global fold
determination, where restraints can be obtained for all peaks
that are resolved and assigned in the 2D 1H-15N HSQC
spectrum (Battiste and Wagner, 2000; Gaponenko et al.,
2000). The approach should be applicable to all proteins
with known structures for which suitable single cysteine
mutants can be obtained. For proteins containing disulfides
or cysteines critical to their function, site-directed spin
labeling of residues other than cysteines could be utilized
(Berliner, 1976; Schmidt and Kuntz, 1984; Hankovszky et
al., 1987; Musci et al., 1988).
There are several limitations to the approach as well. It
will not be applicable to ligands with severely exchange-
broadened or highly overlapped resonances. The distribu-
tion of the spin-labeled side-chain conformations obtained
by simulated annealing may differ from the true distribu-
tion. The precision and accuracy of the restraints will be
affected by random errors associated with measurements of
the paramagnetic contributions and systematic errors arising
from inaccurate estimates of the correlation time and/or
fraction of bound ligand. Nonlinear averaging of the effec-
tive distances due to internal dynamics will also affect the
precision and accuracy of experimental restraints. Given
these considerations, error bounds on the distance restraints
of between 	10% and 	20% are likely to be required.
Nevertheless, even with 	20% error bounds, a moderately
well defined binding mode was obtained when a few sup-
plementary short-range restraints were included (Table 2).
Supplementary short-range distance restraints could be
obtained in several different ways. For proteins that can be
partially assigned, residue-type-specific labeling can be ap-
plied to obtain protein-ligand NOEs. For proteins that can-
not be assigned, SDSL restraints could be used to check
binding modes produced by docking programs (Lambert,
1997) for consistency. Distance restraints reflecting key
interactions could be derived from alternate binding modes
suggested by docking and used in conjunction with SDSL
restraints in structure calculations.
The simulated annealing protocol used to randomize the
spin-labeled side chains produced a wide sampling of con-
formational space (Figs. 2 and 5). This probably represents
a worst-case scenario regarding the flexibility of these side
chains, because it is known from electron paramagnetic
resonance (EPR) studies (Mchaourab et al., 1996, 1999) and
crystallographic studies (Langen et al., 2000) that the actual
conformational mobility may be restricted. For proteins
with backbone assignments, distance restraints from the
spin-labeled side chains to backbone amide protons (Bat-
tiste and Wagner, 2000; Gaponenko et al., 2000) could be
used in conjunction with restraints to the ligand to further
restrict the conformational freedom of the system. With a
larger database of crystallographic information, with the
acquisition of EPR information, and/or with the use of more
conformationally restricted spin labels, it may become pos-
sible to place a priori restrictions on the spin-labeled side-
chain conformations. The currently available crystallo-
graphic data (Langen et al., 2000) indicate that g 1
rotamer of the spin-labeled side chain used here is disfa-
vored.
Finally, the flexibility of the protein will need to be
addressed if a given ligand produces changes in the pro-
tein’s conformation relative to the available structures. For
relatively small changes, it should be sufficient to allow a
more extensive region of the complex to relax during a final
restrained energy minimization. More extensive changes
will likely require the incorporation of additional informa-
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tion, such as intra-protein NOEs and SDSL restraints to the
protein, to accurately define the structure of the complex.
CONCLUSIONS
The results reported in this article indicate that protein-
ligand SDSL restraints have the potential of providing valu-
able information on ligand binding modes. When combined
with several short-range restraints, the overall ligand bind-
ing mode can be defined relatively well. The combined
restraints yield a significant improvement over results ob-
tained using either short-range or SDSL restraints alone.
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anethiosulfonate. Careful readings of the manuscript by Drs. Mark
Friedrichs, Luciano Mueller, Patricia McDonnell, and William Metzler are
gratefully acknowledged. The distance restraints used to calculate the
structural ensembles are available upon request.
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